Intellectual Property India Publishes Patent Application for 'Pluripotent Stem Cell-Derived T Cell Populations And Progenitors Thereof' Filed by Garuda Therapeutics, Inc.

MUMBAI, India, Aug. 8 -- Intellectual Property India has published a patent application (202517042277 A) filed by Garuda Therapeutics, Inc., Cambridge, U.S.A., on May 1, for 'pluripotent stem cell-derived t cell populations and progenitors thereof.'

Inventor(s) include Shah, Dhvanit.

The application for the patent was published on Aug. 8, under issue no. 32/2025.

According to the abstract released by the Intellectual Property India: "In various aspects and embodiments, the present disclosure provides methods for generating T cell populations for cell therapy, including T lymphocytes (T cells) and progenitor T cells. In various embodiments, the invention provides for efficient ex vivo processes for developing progenitor T cells and T cell...